External Device for Erectile Dysfunction (3D-Erect)
3D-Erect
Non-invasive External Device for Erectile Dysfunction (3D-Erect): a Pilot Study
1 other identifier
interventional
9
1 country
1
Brief Summary
The aim of this clinical trial is to test the safety and feasibility of a non-invasive 3D-printed external penile device to achieve successful and satisfactory sexual intercourse in men with erectile dysfunction (ED).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2021
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 3, 2020
CompletedFirst Posted
Study publicly available on registry
November 10, 2020
CompletedStudy Start
First participant enrolled
July 10, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
January 13, 2026
January 1, 2026
5.4 years
November 3, 2020
January 12, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Change in modified International Index of Erectile Dysfunction score
score 0 to 30 with higher score meaning overall better erectile function
baseline and up to 1 month post-baseline
Study Arms (1)
3D-Erect arm
EXPERIMENTALParticipants will be asked to use the 3D-printed penile device during their intercourse with partners.
Interventions
Eligibility Criteria
You may qualify if:
- males \>18 years old suffering from any cause moderate to severe erectile dysfunction (e.g. ED after radical prostatectomy and/or radiation therapy for prostate cancer and or other pelvic malignancies affecting the sexual potency; emotional and psychological ED; organic vascular and/or metabolic ED etc.)
- having a female partner willing to participate in the study.
You may not qualify if:
- not willing to attempt sexual vaginal intercourse with their partner
- inability to wear/operate the external penile device for any reason
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Stanford Health Care, Stanford Hospital
Stanford, California, 94305, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael Eisenberg, MD
Stanford University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DEVICE FEASIBILITY
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Urology
Study Record Dates
First Submitted
November 3, 2020
First Posted
November 10, 2020
Study Start
July 10, 2021
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
January 13, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share